Invention Grant
- Patent Title: Antiviral heterocyclic compounds
-
Application No.: US17894412Application Date: 2022-08-24
-
Publication No.: US12006326B2Publication Date: 2024-06-11
- Inventor: Adam Szymaniak , Kevin McGrath , Jianming Yu , Tyler Mann , Long Nguyen , Kaicheng Zhu , In Jong Kim , Yat Sun Or
- Applicant: Enanta Pharmaceuticals, Inc.
- Applicant Address: US MA Watertown
- Assignee: Enanta Pharmaceuticals, Inc.
- Current Assignee: Enanta Pharmaceuticals, Inc.
- Current Assignee Address: US MA Watertown
- Agency: Elmore Patent Law Group, P.C.
- Agent Edgar W. Harlan; Carolyn S. Elmore
- Main IPC: C07D491/052
- IPC: C07D491/052 ; C07D471/04 ; C07D491/044 ; C07D491/048
Abstract:
The present invention discloses compounds of Formula (I), or pharmaceutically acceptable salts, esters, or prodrugs thereof:
which inhibit Human Respiratory Syncytial Virus (HRSV) or Human Metapneumovirus (HMPV) inhibitors. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject suffering from HRSV or HMPV infection. The invention also relates to methods of treating an HRSV or HMPV infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention.
which inhibit Human Respiratory Syncytial Virus (HRSV) or Human Metapneumovirus (HMPV) inhibitors. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject suffering from HRSV or HMPV infection. The invention also relates to methods of treating an HRSV or HMPV infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention.
Public/Granted literature
- US20230125803A1 ANTIVIRAL HETEROCYCLIC COMPOUNDS Public/Granted day:2023-04-27
Information query
